Pages that link to "Q44198087"
Jump to navigation
Jump to search
The following pages link to Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen (Q44198087):
Displaying 16 items.
- Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia (Q33392788) (← links)
- Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Ne (Q34645147) (← links)
- Transplantation for congenital bone marrow failure syndromes (Q35428973) (← links)
- Dyskeratosis congenita: its link to telomerase and aplastic anaemia (Q35558515) (← links)
- Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). (Q35597309) (← links)
- The hope and the reality of reduced intensity transplants in children with malignant diseases (Q36090213) (← links)
- Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita (Q36591308) (← links)
- Reduced-intensity conditioning in children: a reappraisal in 2008. (Q37188472) (← links)
- The genetics and clinical manifestations of telomere biology disorders (Q37300909) (← links)
- Telomeres and human health (Q38152802) (← links)
- Fludarabine, low-dose cyclophosphamide and rabbit antithymocyte globulin allowed stable engraftment after allogeneic peripheral blood stem cell transplantation for poly-transfused dyskeratosis congenita patient: case report (Q45800411) (← links)
- Usual interstitial pneumonia complicating dyskeratosis congenita (Q47783078) (← links)
- Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. (Q53330217) (← links)
- Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan (Q80854398) (← links)
- Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen (Q81311486) (← links)
- Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita (Q90485064) (← links)